Investigating how certain lipids affect bacterial infections
Official title: Roles of novel cationic lipids in bacterial pathogenesis
Funded at University of Texas Dallas · NIH-11083692 · Data updated 2026-11-12
This study is looking at how certain new lipids in the membranes of Gram-positive bacteria affect their survival and how they interact with our bodies, especially in relation to serious conditions like meningitis, with the hope of finding new ways to treat bacterial infections.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Dallas NIH-funded |
| Lab location | 1 site (Richardson, United States) |
| Project start | June 1, 2023 |
| Project end | May 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $649,409 |
| NIH project number | 5R01AI178692-03 |
| Project ID | NIH-11083692 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at risk for infections caused by Gram-positive bacteria, particularly those susceptible to meningitis.
✕Less likely to help
Patients with infections caused by Gram-negative bacteria or those not at risk for bacterial infections may not benefit from this research.
What this research studies
This research focuses on understanding the role of novel cationic lipids in the membranes of Gram-positive bacteria, particularly how they influence bacterial survival and interactions with the human host. The study aims to explore how these lipids can disrupt the blood-brain barrier, which is crucial for understanding bacterial pathogenesis in diseases like meningitis. By examining the mechanisms of barrier disruption and the role of bacterial membrane vesicles, the research seeks to fill significant knowledge gaps in how these pathogens operate. Patients may benefit from insights gained that could lead to new therapeutic strategies against bacterial infections.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that prevent bacterial infections from breaching the blood-brain barrier, potentially reducing the incidence of meningitis and other serious conditions.
How similar studies have gone: While the specific approach of investigating cationic lipids in this context is novel, similar studies have shown promise in understanding bacterial pathogenesis and developing antimicrobial strategies.
Where this research is happening
-
University of Texas Dallas
Richardson, United States Active
Researchers
- Principal investigator: Palmer, Kelli Lea — University of Texas Dallas
- Study coordinator: Palmer, Kelli Lea
Related research
Other NIH-funded projects on the same topics.
-
Profilin as a Target to Normalize Tumor Vessels in Kidney Cancer
A new approach aims to curb blood vessel growth in a common kidney cancer by targeting a protein called Profilin 1 to improve how blood vessels form in tumors.
-
Ultrafast debinding for chairside 3D-printed zirconia dental restorations
A new ultrafast debinding method aims to dramatically shorten how quickly chairside 3D-printed zirconia dental crowns can be made.
-
Adolescents learning about themselves through friends and how it links to mood
A study with teens will test how feedback from close friends and strangers shapes their self-views and mood, using brain and behavior measurements.
-
Bilingual children with developmental language disorder: how two languages shape brain development
A study with bilingual kids who have developmental language disorder to see how knowing two languages affects their brain and language skills.
-
BET inhibitors as a potential therapy for solitary fibrous tumor (SFT)
Aimed at adults with solitary fibrous tumor, this grant explores BET inhibitors to block tumor-driving gene activity.
-
Estrogen, puberty, and early signs of psychosis in teens
This grant looks at how rising estrogen during puberty in girls may influence early brain changes and psychotic-like experiences as kids become teens.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.